First City Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Sell
6,107
-15
-0.2% -$15.3K 3.56% 4
2026
Q1
$5.63M Sell
6,122
-76
-1% -$77K 2.98% 7
2025
Q4
$6.66M Sell
6,198
-142
-2% -$136K 3.52% 4
2025
Q3
$4.84M Buy
6,340
+96
+2% +$71.4K 2.61% 11
2025
Q2
$4.87M Sell
6,244
-89
-1% -$69.2K 2.81% 9
2025
Q1
$5.23M Sell
6,333
-1,862
-23% -$1.55M 3.14% 9
2024
Q4
$6.33M Sell
8,195
-172
-2% -$142K 3.37% 5
2024
Q3
$7.41M Sell
8,367
-109
-1% -$98K 3.81% 4
2024
Q2
$7.67M Sell
8,476
-414
-5% -$331K 4.31% 2
2024
Q1
$6.92M Sell
8,890
-1,312
-13% -$934K 3.83% 3
2023
Q4
$5.95M Sell
10,202
-168
-2% -$98.1K 3.45% 4
2023
Q3
$5.57M Sell
10,370
-1,732
-14% -$892K 3.5% 3
2023
Q2
$5.68M Sell
12,102
-808
-6% -$339K 3.35% 3
2023
Q1
$5.11M Buy
12,910
+256
+2% +$86.3K 2.99% 5
2022
Q4
$4.63M Sell
12,654
-865
-6% -$307K 2.79% 6
2022
Q3
$4.37M Sell
13,519
-258
-2% -$81.7K 2.88% 5
2022
Q2
$4.47M Sell
13,777
-107
-0.8% -$32.1K 2.75% 6
2022
Q1
$3.98M Buy
13,884
+206
+2% +$53K 2.19% 7
2021
Q4
$3.31M Sell
13,678
-1,036
-7% -$263K 1.86% 10
2021
Q3
$3.4M Buy
14,714
+48
+0.3% +$11.8K 1.91% 6
2021
Q2
$3.86M Buy
14,666
+76
+0.5% +$15.3K 2.12% 5
2021
Q1
$2.82M Sell
14,590
-730
-5% -$143K 1.63% 12
2020
Q4
$3.1M Sell
15,320
-15,018
-50% -$2.24M 1.98% 5
2020
Q3
$4.5M Buy
30,338
+13,135
+76% +$2.03M 1.67% 7
2020
Q2
$2.82M Buy
17,203
+504
+3% +$77.4K 2.17% 5
2020
Q1
$2.32M Sell
16,699
-804
-5% -$110K 2.27% 8
2019
Q4
$2.3M Sell
17,503
-125
-0.7% -$14.5K 1.58% 13
2019
Q3
$1.97M Sell
17,628
-1,929
-10% -$215K 1.44% 15
2019
Q2
$2.17M Sell
19,557
-20
-0.1% -$2.35K 1.58% 13
2019
Q1
$2.54M Sell
19,577
-845
-4% -$103K 1.83% 8
2018
Q4
$2.36M Sell
20,422
-944
-4% -$105K 1.84% 8
2018
Q3
$2.29M Sell
21,366
-575
-3% -$57.5K 1.52% 11
2018
Q2
$1.87M Sell
21,941
-350
-2% -$28.7K 1.34% 19
2018
Q1
$1.73M Hold
22,291
1.29% 23
2017
Q4
$1.88M Sell
22,291
-650
-3% -$55.3K 1.28% 23
2017
Q3
$1.96M Sell
22,941
-445
-2% -$36.5K 1.37% 17
2017
Q2
$1.93M Sell
23,386
-99
-0.4% -$8.08K 1.4% 17
2017
Q1
$1.98M Hold
23,485
1.45% 15
2016
Q4
$1.73M Buy
23,485
+62
+0.3% +$4.62K 1.3% 21
2016
Q3
$1.88M Sell
23,423
-550
-2% -$44K 1.44% 16
2016
Q2
$1.89M Sell
23,973
-225
-0.9% -$16.9K 1.43% 18
2016
Q1
$1.74M Sell
24,198
-1,064
-4% -$80.5K 1.19% 18
2015
Q4
$2.13M Sell
25,262
-150
-0.6% -$12.4K 1.43% 11
2015
Q3
$2.13M Sell
25,412
-175
-0.7% -$14.8K 1.56% 9
2015
Q2
$2.14M Sell
25,587
-174
-0.7% -$13.3K 1.48% 11
2015
Q1
$1.87M Sell
25,761
-228
-0.9% -$16.2K 1.29% 16
2014
Q4
$1.79M Sell
25,989
-180
-0.7% -$12.2K 1.24% 16
2014
Q3
$1.7M Hold
26,169
1.22% 16
2014
Q2
$1.63M Sell
26,169
-200
-0.8% -$11.9K 1.16% 16
2014
Q1
$1.55M Sell
26,369
-600
-2% -$33.5K 1.11% 20
2013
Q4
$1.38M Sell
26,969
-1,885
-7% -$94.4K 1.13% 25
2013
Q3
$1.45M Buy
28,854
+300
+1% +$15.7K 1.2% 22
2013
Q2
$1.4M Buy
+28,554
New +$1.55M 1.28% 21

Other funds holding LLY

First City Capital Management's LLY Position: Q2 2026 in Review

First City Capital Management reduced its Eli Lilly (LLY) stake by 0.25% in Q2 2026, selling an estimated $15.3K and leaving 6,107 shares worth $7.32M. The position accounts for 3.56% of the portfolio, ranked #4.

First City Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.67M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First City Capital Management held 6,107 shares of Eli Lilly worth $7.32M as of Q2 2026.
  • First City Capital Management sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 3.56% of First City Capital Management's portfolio in Q2 2026, its #4 holding.
  • First City Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • First City Capital Management's Eli Lilly position peaked at $7.67M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.